Board - Patient Focused Medicines Development

PFMD Board

PFMD has from inception been formed as an equal collaboration among its members which includes patient groups, patients, the pharmaceutical industry and regulators. The leadership and governance model adopted by PFMD ensures at least equal or greater share of voice for patient groups. PFMD activities are funded and supported by member organisations.

Nicola Bedlington
Secretary General, European Patients Forum
Veronica Todaro
Vice President, National Programs, Parkinson’s Disease Foundation
Graeme Johnston
Patient Advocate, Individual/ Patient
Alexandra Moutet
Global Head of Patient Affairs, UCB
Andrew Benzie
Head of Patients in Partnership Programme, GSK
Jan Nissen
VP Patient Innovation & Engagement, Merck
Katherine Capperella
Global Patient Engagement Leader, Janssen
Sanja Njegic
Global Head Of Patient Partnership, Roche
Elisa Ferrer
Patient Engagement Manager, EURORDIS
Kelli Collins
Vice President Patient Engagement, National Kidney Foundation
Lode Dewulf
Chief Patient Officer At Servier Group
Begoña Nafría Escalera
Patient Engagement In Research Coordinator- Hospital Sant Joan De Déu
Laura McKeaveney
Global Head Of Patient Advocacy At Novartis
Jan Geissler
Patient Advocate, EUPATI
Neil Bertelsen
Chair, HTAi Patient And Citizen Involvement Interest Group
Jim Elliott
Public Involvement Lead, Health Research Authority
Esther Krofah
Executive Director, FasterCures (A Center Of The Milken Institute)
Anthony Yanni
SVP And Global Head, Patient Centricity, Astellas Pharma US